Ravalli Dialysis, Llc in Clarksville, Tennessee - Dialysis Center

Ravalli Dialysis, Llc is a medicare approved dialysis facility center in Clarksville, Tennessee and it has 13 dialysis stations. It is located in Montgomery county at 1459 Fort Campbell Blvd, Clarksville, TN, 37042. You can reach out to the office of Ravalli Dialysis, Llc at (931) 552-6491. This dialysis clinic is managed and/or owned by Davita. Ravalli Dialysis, Llc has the following ownership type - Profit. It was first certified by medicare in October, 2017. The medicare id for this facility is 442742 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameRavalli Dialysis, Llc
Location1459 Fort Campbell Blvd, Clarksville, Tennessee
No. of Dialysis Stations 13
Medicare ID442742
Managed ByDavita
Ownership TypeProfit
Late Shifts No

Contact Information


1459 Fort Campbell Blvd, Clarksville, Tennessee, 37042
(931) 552-6491
Not Available

News Archive

Vitamin E is one of the first lines of defense in human lung tissue against the ravages of cigarette smoke

A new study has found that supplements of vitamin C can largely stop the serious depletion of vitamin E that occurs in smokers, demonstrating for the first time in humans a remarkable interaction between these two antioxidants as they work together.

Wrong diagnosis makes comedian spend his life savings

A British comedian ended up spending his life savings after he was wrongly told by doctors he only had three months to live.

Many women skip scientific conferences because of family obligations, study finds

For oncologists in the beginning of their career, scientific conferences present an opportunity to network, share their research, gain new knowledge and begin to advance in their career. But many women find themselves skipping these conferences because of family obligations, a new study finds.

Idera collaborates with TMA to advance new potential treatment approach for myositis

Idera Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing nucleic acid therapeutics for patients with cancer and rare diseases, and The Myositis Association (TMA), the only nonprofit organization dedicated to solely serving all patients with inflammatory myopathies, today announced a collaboration to advance a new potential treatment approach for polymyositis and dermatomyositis known as Toll-like receptor (TLR) antagonism.

Read more Medical News

› Verified 2 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Ravalli Dialysis, Llc from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1588118897
Organization NameFort Campbell Dialysis
Doing Business AsRavalli Dialysis, Llc
Address1459 Fort Campbell Blvd Clarksville, Tennessee, 37042
Phone Number(615) 341-6838

News Archive

Vitamin E is one of the first lines of defense in human lung tissue against the ravages of cigarette smoke

A new study has found that supplements of vitamin C can largely stop the serious depletion of vitamin E that occurs in smokers, demonstrating for the first time in humans a remarkable interaction between these two antioxidants as they work together.

Wrong diagnosis makes comedian spend his life savings

A British comedian ended up spending his life savings after he was wrongly told by doctors he only had three months to live.

Many women skip scientific conferences because of family obligations, study finds

For oncologists in the beginning of their career, scientific conferences present an opportunity to network, share their research, gain new knowledge and begin to advance in their career. But many women find themselves skipping these conferences because of family obligations, a new study finds.

Idera collaborates with TMA to advance new potential treatment approach for myositis

Idera Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing nucleic acid therapeutics for patients with cancer and rare diseases, and The Myositis Association (TMA), the only nonprofit organization dedicated to solely serving all patients with inflammatory myopathies, today announced a collaboration to advance a new potential treatment approach for polymyositis and dermatomyositis known as Toll-like receptor (TLR) antagonism.

Read more Medical News

› Verified 2 days ago


Patient Distribution